Unlock instant, AI-driven research and patent intelligence for your innovation.

Phascolarctobacterium faecium for use in the prevention and treatment of obesity and its comorbidities

A technology of strains and uses, applied in the pharmaceutical and food fields, can solve the problems of no provision, reduction of tubular bacteria, no provision, etc.

Pending Publication Date: 2021-10-22
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Regarding the possible beneficial properties of the Phascolarctobacterium genus, a published study in rats showed that drug treatments for diabetes (berberine and metformin) altered the microbiota and resulted in different bacterial groups (Heterobacillus, Bacteroides, Blautia , Butyricicoccus, and Phascolarctobacterium); this led to speculation that this overall alteration in the microbiota might be part of the mode of action of antidiabetic drugs, but provided no direct evidence
In a study of rats fed a high-fat diet with and without physical exercise, a high-fat diet was found to be associated with a reduction in Firmicutes and reduced running ability, as well as a reduction in Tubularbacteria; this led to speculation that this A change in the microbiota may be partly responsible for the positive effects of physical activity on fatty liver; however, no direct evidence for this is given

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Phascolarctobacterium faecium for use in the prevention and treatment of obesity and its comorbidities
  • Phascolarctobacterium faecium for use in the prevention and treatment of obesity and its comorbidities
  • Phascolarctobacterium faecium for use in the prevention and treatment of obesity and its comorbidities

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0085] Example 1. Separation and identification of bacterial strain P.faecium G104 (P.Faecium DSM 32890)

[0086] Different intestinal bacteria are separated from the feces of healthy volunteers. 1.25 g was diluted with 10 mM phosphate buffer containing 0.05% cysteine ​​(1: 10 dilution), wherein the NaCl concentration was 130 mm (PBS) and in Lab-Blender Stomacher 400 (Seward Medical, London, Homogenization in 35uk. The dilute solution was inoculated in 37.5 ml of small intestinal bacteria medium (IBM), which was based on the medium recommended by previous publications (Gibson, GR, etal., Appl.environ MiCrobiol., 54 (1 1): 2750-5, 1988; Lesmes, u et al., J.agric.foodchem., 56: 5415-5421, 2008), and inventors have designed some modifications:

[0087] ■ Main ingredients: Distilled water (1600 mL), protein water (4 g), sodium bicarbonate (4 g), calcium chloride (0.02 g), pectin (4 g), xylosan (4 grams), wheat bran Extract (4 g), Arabic hemarylose (2g), Arabic (2 g), starch (10 g), ca...

Embodiment 2

[0102] Example 2. Select P. Faecium based on its ability to regulate inflammation in vitro.

[0103] In vitro assays to compare the immunoassay characteristics of human intestinal sources bacteria, and select a strain capable of inducing maximum anti-inflammatory responses in classic monocytes, therefore has potential treatment value in the treatment of obesity-related inflammation. For this reason, the cell suspension of different bacterial strains is used as irritation in peripheral blood mononuclear cells (PBMC) culture, and the number of classic mononuclear cells is measured by flow cytometry and anti-inflammatory cytokines IL-4 relative to promotion. Level of inflammatory cytokine IFNγ.

[0104] Culture and stimulation of PBMC.

[0105] From the full blood of healthy volunteers, peripheral blood mononuclear cells (PBMC) were separated using FICOLL PAQUE-PLUS 17-1440-02, Bioscience. After dissolving red blood cells (red blood cell lysis buffer, RBC, Miltenyi Biotec. Gibco, Sp...

Embodiment 3

[0112] Example 3. Role of P.Faecium in the obese animal model

[0113] Development of obesity and sampling animal model.

[0114] Adult male C57BL / 6 mice (6-8 weeks, Charles River, Les Oncins, FRANCE) were held in controlled temperature (23 ° C), relative humidity (40-50%) and 12 hours of light / dark cycle conditions High fat (45% kcal) High sugar (sucrose) (17% kcal) High-calorie diet (HFHSD; D12451, study diet, BROGAARDEN, Denmark) or control diet (CD, 10% Kcal from fat, no sucrose; D12450K To study diet, BROGAARDEN, Denmark 14 weeks. Each day, mice feeding HFHSD diet are subject to the bacterial strain of the invention in 10% degreased milk [(1 × 10) 7 -1 × 10 -8 ) Colony forming unit (CFU)]. In the same manner, the carrier (10% degreasing milk) was administered to the control group and the slope (CD) control group (N = 10 mice per group). After 14 weeks, mice were killed by cervical spine, taking blood, intestines, liver, brain, groin and epididymis, white adipose tissue, ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The present invention relates to the strain Phascolarctobacterium faecium DSM 32890 and to its use for the regulation of appetite and the treatment and / or prevention of overweight or the associated metabolic and immunological changes, specifically, hyperglycaemia, glucose intolerance, insulin resistance, dyslipidemia (hypertriglyceridemia, hypercholesterolemia), metabolic syndrome, diabetes and intestinal and / or peripheral tissue inflammation.

Description

Technical field [0001] The invention is within the field of pharmaceutical and food. In particular, the present invention relates to a strain of a deposit number DSM 32890, a cellular component, a metabolite, and a secretion molecule, a composition, and / or any combination thereof. It is particularly related to strain P.faecium (Slap Totaclona) DSM 32890 is used to regulate appetite, and treatment and / or prevent overweight and / or obesity and related metabolism, especially hyperglycemia, glucose resistance. Poor, insulin resistance, blood lipid abnormal (high glycid triammia, high cholesterolemia), metabolic syndrome, diabetes, liver fatty degeneration, cardiovascular disease and intestinal and / or peripheral tissue inflammation. Background technique [0002] Obesity is one of the main public health issues, as it has high prevalence, the complications, greatly reduce the quality of life and increase the risk of death. These complications include, for example, blood fat abnor...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C12N1/20A61K35/741A23L33/135
CPCC12R2001/01C12N1/205A23L33/135A61K8/99A61K35/74A61K35/745A61K35/747A61K35/741A61K35/744A61K2035/115A61Q19/06A61K2300/00C12N1/20
Inventor Y·桑兹·赫兰兹I·洛佩兹·阿尔梅拉E·M·戈麦斯·德尔·普贾·维拉努瓦A·贝尼特斯-佩兹M·罗曼尼·佩雷斯
Owner CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)